30 May, 2014 by The TZ Newswire Staff Comments Off on Has The Next Recession Already Begun For America’s Middle Class?
Has The Next Recession Already Begun For America’s Middle Class?
Submitted by Michael Snyder of The Economic Collapse blog,
30 May, 2014 by The TZ Newswire Staff Comments Off on Stocks on Our Radar: 3D Systems
Stocks on Our Radar: 3D Systems
In this edition of our brand-new “Stocks on Our Radar” series, analysts Simon Erickson and Sara Hov take a look at 3D Systems.
30 May, 2014 by The TZ Newswire Staff Comments Off on Why SunPower’s Colorado Project Is a Big Deal
Why SunPower’s Colorado Project Is a Big Deal
SunPower should add about $100 million in value for shareholders with a recently announced project.
30 May, 2014 by The TZ Newswire Staff Comments Off on Why Splunk, Infoblox, and Lions Gate Entertainment Tumbled Today
Why Splunk, Infoblox, and Lions Gate Entertainment Tumbled Today
Major stock market benchmarks hit all-time record highs Friday, but these three stocks got the short end of the stick.
30 May, 2014 by The TZ Newswire Staff Comments Off on Samsung Electronics Co Ltd Pulls a Switcheroo on Google
Samsung Electronics Co Ltd Pulls a Switcheroo on Google
Samsung swaps out Android for Tizen in its original Galaxy Gear. Is the conglomerate simply hedging its bets?
30 May, 2014 by The TZ Newswire Staff Comments Off on Insider Trading Bombshell: FBI/SEC Investigating Carl Icahn & Phil Mickelson
Insider Trading Bombshell: FBI/SEC Investigating Carl Icahn & Phil Mickelson
Did you hear the one about the Vegas gambler, the Pro golfer, and the Wall Street insider? Straight off the pages of some Hollywood script, the Wall Street Journal reports that Federal investigators are pursuing a major insider-trading probe involving finance, gambling and sports, examining the trading of investor Carl Icahn, golfer Phil Mickelson and Las Vegas bettor William “Billy” Walters.
30 May, 2014 by The TZ Newswire Staff Comments Off on Is This Really the Best Pipeline In Biotech?
Is This Really the Best Pipeline In Biotech?
ISIS Pharmaceuticals Inc. got a bump from Wall Street after its blood thinner received some positive clinical results.